Alpha Profiles · Company Profile

JOHNSON & JOHNSON

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field.

https://registry.alpha.ac/companies/johnson-johnson

Entity: Public listing published
Primary listing: NYSE: JNJ
Verification: Partially verified
Last reviewed: 2026-09-11T22:12:06.218+00:00

Overview

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories.

Canonical AEGIS identity graph

Executive leadership

Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.

Executive team

10 public records

Elizabeth Forminard

Executive Vice President, Chief Legal Officer

State: confirmed
Effective: Date not stated
Confidence: 94%
Evidence: JNJ executive roster sourceMay 3, 2026

James Swanson

Executive Vice President, Chief Information Officer

State: confirmed
Effective: Date not stated
Confidence: 94%
Evidence: JNJ executive roster sourceMay 3, 2026

Jennifer Taubert

Executive Vice President, Worldwide Chairman, Innovative Medicine

State: confirmed
Effective: Date not stated
Confidence: 94%
Evidence: JNJ executive roster sourceMay 3, 2026

Joaquin Duato

Chairman of the Board; Chief Executive Officer

State: confirmed
Effective: Date not stated
Confidence: 94%
Evidence: JNJ executive roster sourceMay 3, 2026

Joseph J. Wolk

Executive Vice President, Chief Financial Officer

State: confirmed
Effective: Date not stated
Confidence: 94%
Evidence: JNJ executive roster sourceMay 3, 2026

Joshua Reed

Executive Vice President, Innovative Medicine, R&D

State: confirmed
Effective: Date not stated
Confidence: 94%
Evidence: JNJ executive roster sourceMay 3, 2026

Kathryn E. Wengel

Executive Vice President, Chief Technical Operations Risk Officer

State: confirmed
Effective: Date not stated
Confidence: 94%
Evidence: JNJ executive roster sourceMay 3, 2026

Kristen Mulholland

Executive Vice President, Chief Human Resources Officer

State: confirmed
Effective: Date not stated
Confidence: 94%
Evidence: JNJ executive roster sourceMay 3, 2026

Tim Schmid

Executive Vice President, Worldwide Chairman, MedTech

State: confirmed
Effective: Date not stated
Confidence: 94%
Evidence: JNJ executive roster sourceMay 3, 2026

Vanessa Broadhurst

Executive Vice President, Global Corporate Affairs

State: confirmed
Effective: Date not stated
Confidence: 94%
Evidence: JNJ executive roster sourceMay 3, 2026

Governance leadership

Boards & Committees

Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.

Record as of Sep 11, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.